Got a Rash After Injecting Mounjaro? Here's What's Happening

Injection-site redness, itching or mild swelling is a recognised and commonly reported side effect of Mounjaro, noted in the medicine's Summary of Product Characteristics.
Most localised reactions improve without treatment as the body adjusts, particularly in the early weeks or after a dose increase.
A rash that spreads beyond the injection site, or comes with breathing difficulty or swelling of the face and throat, needs urgent medical attention.
Simple technique changes (rotating sites, injecting at room temperature, using a fresh needle each time) reduce how often these reactions occur.

A red, itchy patch at the spot where you injected Mounjaro is one of the most common things people notice in the first weeks of treatment. Most of the time it is a mild, localised reaction that settles on its own within a day or two. Occasionally it signals something worth looking into. Mounjaro (tirzepatide) is a prescription-only medicine, and any persistent or spreading skin reaction should be discussed with the prescriber who oversees your treatment — not left to resolve by guesswork.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding injection-site reactions to Mounjaro: causes, patterns and practical steps

Why does Mounjaro cause a skin reaction at the injection site?

Tirzepatide is delivered subcutaneously (beneath the skin) into a layer of fatty tissue. The body's immune system notices the injection itself (the needle, the volume of fluid, any small variation in technique) and mounts a mild local response. Redness, warmth, minor swelling and itching are all part of that ordinary process. The reaction is not the medicine being rejected; it is the skin doing what skin does when it is punctured and a foreign substance enters.

Several things can make the reaction more noticeable. Injecting cold fluid straight from the fridge is a common culprit — letting the pen sit at room temperature for about 30 minutes before use can take the edge off. Repeatedly using the same spot without rotating means the tissue never fully recovers between doses. The full Mounjaro injection guide covers all of this in detail, including which sites to use and how far apart to keep them.

The NHS notes injection-site reactions as an expected, recognised side effect of tirzepatide, and the medicine's own patient information leaflet lists redness, itching and swelling at the injection site among the most commonly reported effects. The NHS tirzepatide medicine page has a clear breakdown of what to expect and what to watch for.

What does a normal injection-site rash look like, and how long should it last?

A typical localised reaction is a pink or red patch, sometimes raised slightly, roughly the size of a 50p coin or a little larger, appearing within an hour or so of the injection and fading over 24 to 72 hours. It may itch. It may be slightly warm to touch. It is usually flat or only very mildly raised, and it does not spread far from the injection point.

If you are in the first few weeks of treatment, or you have just moved up a dose, these reactions tend to be most pronounced and then settle as your body adjusts. That pattern is well documented. A small, firm lump that persists for longer than a week or two can sometimes develop, this is worth flagging at your next prescriber review; read more about lumps at the injection site if that is what you are seeing.

Timing can affect how you perceive the reaction too. Someone injecting on a Friday evening before a bank holiday weekend, for instance, may feel more anxious about a red patch with no easy access to clinical advice, that is exactly why having clear answers to hand and a service with seven-day aftercare matters.

When is a rash after injecting Mounjaro a reason to seek help?

Most reactions are localised and benign. A smaller number are not, and it is important to know the difference. If you want a closer look at what to expect, our guide to rash after Mounjaro injection covers the full range of presentations and when each one warrants attention. Contact your prescriber or GP if the redness spreads significantly beyond the original injection area, if the skin feels hard, very hot or becomes painful rather than just itchy, or if you develop a fever alongside the skin change. These could point to an infection at the injection site, particularly if technique or site hygiene needs adjustment, cleaning the area before injection with an alcohol swab is a simple and effective step.

Call 999 or go to A&E immediately if a rash appears alongside any of the following: difficulty breathing, tightness in the throat or chest, rapid swelling of the lips, face or tongue, or feeling faint. These are signs of a serious allergic reaction (anaphylaxis) and need emergency treatment. The MHRA's Yellow Card scheme allows patients and healthcare professionals to report serious or unexpected reactions, if you experience something severe, that report helps regulators monitor the medicine's safety profile for everyone who uses it.

If you are seeing a rash pattern that does not fit the localised description above, our page on Mounjaro injection rash explores the different presentations in more detail, including widespread hives, a rash on a different part of the body from the injection site, or itching all over, all of which warrant a conversation with your prescriber promptly. It is a different clinical picture from a routine injection-site reaction, and a prescriber needs to decide whether it is related to the medicine or something else entirely.

Can you reduce the chances of a rash happening again?

Yes, and most of the practical steps are straightforward. Rotate between the three approved sites (abdomen, outer thigh and upper arm) keeping each injection at least a few centimetres from the previous one. Do not reuse a needle; a fresh needle means a sharper tip and far less tissue trauma. If you need to replace needles regularly, our pharmacy stocks compatible needles for that purpose.

Let the pen warm up before you use it. Inject slowly and steadily rather than rushing the dose. After withdrawing the needle, apply gentle pressure with a clean fingertip but do not rub, rubbing can spread the medicine into surrounding tissue and worsen the local response. Keep a mental note of which sites you have used so you are not inadvertently returning to a spot that has not had a week to recover.

If reactions remain a problem despite good technique, our detailed page on Mounjaro rash at the injection site is worth reading before your next clinical review, as it covers the adjustments to approach or timing that a prescriber can help with. Thinking about starting treatment, or wondering what the injection process actually involves day to day? This overview of using Mounjaro walks through the full practical picture. And if you are weighing up the broader treatment landscape, our treatment overview sets out what is licensed in the UK for weight management. Our clinical team is available seven days a week if you have questions that need a prescriber's view. When you are ready, you can check your eligibility for a consultation with no obligation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions